The QualityStocks Daily Thursday, June 4th, 2020

Today's Top 3 Investment Newsletters

StockMarketWatch (TMDI) +467.07%

TradersPro (CIDM) +177.10%

InvestorPlace (XSPA) +75.93%

The QualityStocks Daily Stock List

Abacus Health Products, Inc. (ABAHF)

Financial Buzz, TipRanks, Investing News, The Dank Investor, Simply Wall St, New Cannabis Ventures, Morningstar, Penny Stock Hub, OTC Dynamics, Cannanbindex.co, OTC Markets, InvestorX, Dividend Investor, Stockwatch, TradingView, Investors Hangout, OTC.Watch, Stockhouse, Market Wire News, and Market Screener reported earlier on Abacus Health Products, Inc. (ABAHF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Abacus Health Products, Inc. manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemp. It targets its products at the fast growing markets for topical pain relief and therapeutic skincare. The Company’s products are based on proprietary patent-pending technologies developed by Abacus. The Company was founded with a mission to use CBD hemp extract (Cannabis sativa L) as a conduit to deliver the world’s fastest and most effective pain relief products to millions of people worldwide. Abacus Health Products is a subsidiary of Aidance Skincare & Topical Solutions, LLC. The Company lists on the OTC Markets Group’s OTCQB.

Abacus currently offers three lines of products. One is CBD CLINIC™, marketed to the professional practitioner market. The other two are CBDMEDIC™ and Harmony Hemp, marketed to the consumer market. The Company’s products are offered throughout the United States. They are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.

Abacus Health Products is the first company to secure OTC registrations for a family of products blended with CBD hemp extract (Cannabis sativa L). In 2016, Abacus started distribution to healthcare practitioners under the CBD CLINIC brand name. In Q3 of 2018, Abacus launched CBDMEDIC directly to the active fitness and mass retail markets.

CBD CLINIC products are formulated to support quick and lasting relief from joint and muscle pain. A proprietary blend of natural emollients facilitates deeper and speedier absorption of pain-relieving compounds to interrupt pain signaling. Moreover, CBDMEDIC products use only naturally-derived analgesic ingredients and 100 percent natural oils to help hasten absorption. The CBDMEDIC line is segmented into three product categories: Active Sport, Back & Neck, and Arthritis.

Abacus Health Products has its CBD CLINIC Massage Therapy Series. This is a line of eight new massage oils and creams. The CBD CLINIC Massage Therapy Series has been developed expressly for massage therapists and other Complementary and Alternative Medicine (CAM) practitioners. The product line offers practitioners different levels of strength and, for the first-time, unscented versions of massage oil and cream.

Last week, Abacus Health Products announced that two independent proxy advisory firms, Institutional Shareholder Services, Inc. and Glass Lewis & Co., each recommended that shareholders of Abacus vote for the proposed acquisition of Abacus by Charlotte’s Web Holdings, Inc. pursuant to an arrangement under the Business Corporations Act (Ontario) at the upcoming special meeting of the Shareholders on June 4, 2020.

In addition, last week, Abacus Health Products reported its financial results for Q1 ended March 31, 2020. Revenue increased 6.5 percent YoY from $3.8 million to $4.1 million. Gross Profit decreased 14 percent YoY from $2.4 million to $2.1 million. Gross Margin decreased YoY to 51.3 percent from 63.3 percent.

CBD CLINIC Revenue decreased YoY from $3.6 million to $2.7 million. CBDMEDIC and Harmony Hemp Revenue increased YoY from $0.3 million to $1.3 million.

Abacus Health Products, Inc. (ABAHF), closed Thursday's trading session at $5.25, up 9.375%, on 5,708 volume with 20 trades. The average volume for the last 3 months is 13,196 and the stock's 52-week low/high is $1.12/$8.39999961.

chart

American Lithium Corp. (LIACF)

NetworkNewsWire, Lithium News, Stock Day Media, Investing Trends, TipRanks, OTC Markets, GlobeNewswire, Wallmine, Northern Miner, Junior Mining Network, IR-WORLD.com, Wallet Investor, TradingView, Market Screener, Stockwatch, AA Stocks, GuruFocus, Investor Ideas, Morningstar, InvestorsHub, Newsfilecorp, Investing Online, Investor Place, Central Charts, Ask Finny, Macroaxis, TMXmoney, Seeking Alpha, MarketWatch, Barchart, Stockhouse, Dividend Investor, Morningstar, and StockInvest.us reported beforehand on American Lithium Corp. (LIACF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

An exploration stage company, American Lithium Corp. engages in the identification, acquisition, exploration for, and development of lithium deposits in the Americas. At present, it is exploring and developing the TLC Project positioned in the highly prospective Esmeralda lithium district in the State of Nevada. The Company previously went by the name Menika Mining Ltd. It changed its name to American Lithium Corp. in April of 2016. Incorporated in 1974, the OTCQB-listed Company is headquartered in Vancouver, British Columbia.

The TLC Project is close to infrastructure, 3.5 hours south of the Tesla Gigafactory. It is in the same basinal environment as Albemarle's Silver Peak lithium mine and several advancing deposits and resources. These include Ioneer Ltd.'s (previously Global Geoscience) Rhyolite Ridge and Cypress Development Corp.'s Clayton Valley project.

American Lithium presently holds a significant land position comprising more than 4,000 acres at its TLC Project near Tonopah, Nevada, one of the most promising and underdeveloped lithium sedimentary basins in North America. The Company’s recent drill program produced core samples up to 2,285 ppm lithium with manifold samples greater than 1,000 ppm lithium.

Near surface sampling has shown as high as 1,690 ppm of lithium and an average 760 ppm lithium to-date. Initial production tests have shown the regional mineralization can result in 90 percent extraction in minutes instead of days or months versus traditional lithium extraction techniques.

Recently, American Lithium announced a mineral resource estimate prepared by Stantec Consulting Ltd. for the Company’s wholly-owned TLC Lithium Claystone property. Highlights include a maiden pit-constrained Resource (at 400 ppm cut-off) of 1.107 billion tonnes Measured and Indicated (M+I) plus 362 Mt Inferred containing 5.37 million tonnes Lithium Carbonate Equivalent (LCE) M+I and 1.76 million tonnes LCE Inferred.

Mr. Michael Kobler, Chief Executive Officer of American Lithium, stated, “We are extremely excited with these results as they confirm the real scale of this project. We now plan to complete more metallurgical work and process testing, followed by an economic evaluation in the form of a prefeasibility study.”

American Lithium Corp. (LIACF), closed Thursday's trading session at $0.33, off by 5.7143%, on 1,171,335 volume with 528 trades. The average volume for the last 3 months is 416,310 and the stock's 52-week low/high is $0.059999998/$0.470699995.

chart
n

Braveheart Resources, Inc. (RIINF)

Zacks, Gold Stock Data, Invezz.com, The Gold Telegraph, Junior Mining Network, Stock Pulse, The Prospector News, Stockhouse, 4-Traders, Seeking Alpha, S&P Global Market Intelligence, Morningstar, Nasdaq, Investing News, TMXmoney, Metals News, Mining and Energy, Proactive Investors, TradingView, Investors Hangout, and Simply Wall St reported previously on Braveheart Resources, Inc. (RIINF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Braveheart Resources, Inc. is a junior mining company centered on building shareholder value through exploration and development in the favourable and proven mining jurisdictions of the East and West Kootenays of British Columbia. It explores for gold, copper, and silver deposits. The Company previously went by the name Rainbow Resources, Inc. It changed its corporate name to Braveheart Resources, Inc. in November of 2014. Braveheart Resources is headquartered in Calgary, Alberta and the Company lists on the OTC Markets’ OTCQB.

Braveheart Resources’ principal asset is the Bull River Mine project that has a current mineral resource containing copper, gold, and silver. This property is completely developed with 21,000 meters of underground developments in terms of ramps, raises, and drifting on mineralized structures on seven levels. The surface infrastructure at the Bull River Mine project includes a 750 tonne per day conventional mill with adjoining crushing facilities and offices and mine maintenance facilities.

The Bull River Mine Project has a large land package including a number of past producers - 9,800 hectares. There is the potential to recover cobalt in a pyrite/cobalt concentrate. The Property is 100 percent owned by Braveheart Resources.

The Bull River Mine property is connected to grid power. There is also year-round access to the site by paved and all-weather roads. The Bull River Project has an Indicated Resource of 1.51 M tonnes @ 2.263 % Cu Eq. It has an Inferred Resource of 0.34 M tonnes @1.86% Cu Eq.

Braveheart Resources is also pursuing the development of its Alpine Mine property near Nelson, British Columbia. This is a past producing, high grade, underground gold mine. The Company’s intention is to truck the Alpine Mine ore to the newly acquired Bull River Mill located in Cranbrook, British Columbia.

In May, Braveheart Resources announced that it received a positive System Impact Study (SIS) from British Columbia Hydro and Power Authority (BCH) on its planned reconnection to grid power at a proposed load of 5 MW. The SIS determined that it is technically feasible to interconnect the proposed Bull River Mine load to the BCH transmission system. The next phase in reconnection to the grid is completion of a Facilities Study (FS) that is required to further define interconnection requirements and establish a time table for BCH's ability to meet Braveheart Resources’ proposed service date.

Braveheart Resources, Inc. (RIINF), closed Thursday's trading session at $0.0331, even for the day, on 25,000 volume. The average volume for the last 3 months is 1,351 and the stock's 52-week low/high is $0.029999999/$0.141599997.

chart

Clinigence Holdings, Inc. (CLNH)

OTC Markets, HealthDatix, Investing.com, Invezz.com, Stock Market Watch, GlobeNewswire, Stockhouse, Morningstar, S&P Global, Simply Wall St, GuruFocus, Stockopedia, Investors Hangout, and InvestorsHub reported beforehand on Clinigence Holdings, Inc. (CLNH), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Clinigence Holdings, Inc., together with its subsidiaries, operates as a healthcare information technology company in the United States. It operates a cloud-based platform that enables healthcare organizations to provide value-based care and population health management. The Company provides advanced analytics-driven solutions to payers and providers to optimize clinical and financial performance. Founded in 2018, Clinigence Holdings is headquartered in Atlanta, Georgia.

Clinigence, LLC and QualMetrix, Inc. merged on March 22, 2019 to become Clinigence Health. Clinigence Health brings together cost and quality data in one unified platform. This is so its customers can make better data-driven decisions to realize higher quality of care at lower total cost. Clinigence Health aggregates and normalizes its client’s multi-source data into its unified cloud-based platform, transforming it into readily available, actionable intelligence that supports important clinical and financial decisions.

Clinigence Health combines Clinigence’s wealth of clinical quality reporting and outcomes improvement tools with QualMetrix’s strong cost and utilization analytics. This is to provide its customers with a completer view of healthcare cost and quality for population health and value-based care.

Clinigence provides turnkey SaaS (Software as a Service) solutions. These solutions enable connected intelligence across the care continuum through transforming vast amounts of data into actionable insights. Its solutions help healthcare organizations improve the quality and cost-effectiveness of care, enhance population health management, as well as optimize provider networks. The Company enables payers, providers, third-party administrators, and other healthcare and life sciences organizations to improve clinical and financial performance, assess, predict, and mitigate risk, and to improve the quality and cost of care.

Clinigence’s platform also aggregates, integrates, and analyzes clinical electronic health record (EHR) and claims data; clinical and quality reports, including HEDIS, STAR, GPRO and MIPS; gaps in care reporting; risk-stratification of patients; predictive analytics; reporting of utilization metrics comprising Admits/1000, Beddays/1000, and ER Visits/1000; and pharmacy utilization analysis. moreover, it also generates a dashboard for each physician, which includes financial, quality, and utilization metrics. Furthermore, the Company offers annual wellness visit and chronic care management services; and wearable devices for remote patient monitoring.

The scalable, purpose-built Clinigence cloud-based platform is in use by manifold health plans, hospitals, independent practice associations/medical groups, accountable care organizations and physicians. It presently has clinical and claims data on more than 7 million patients.

As earlier announced on February 3, 2020, Clinigence and AHA were on the verge of executing a definitive merger agreement to merge the two companies in late January when they received a confidential Letter Of Intent (LOI) to acquire both companies and also a number of roll-up acquisitions from a Nasdaq-listed Special Purpose Acquisition Company (SPAC). The Boards of Directors of both companies made a decision to execute the LOI with the SPAC and to proceed with the process of combining into the SPAC. This process is still continuing, with PCAOB-certified audits of all entities expected to be completed by June 30, 2020. AHA is a foremost medical management platform company.

To increase shareholder value and to facilitate the transaction with the SPAC, the Board of Directors of Clinigence Holdings decided to sell certain assets of the Company to AHA. The sale of the assets was completed on Friday, May 29, 2020. Under the terms of the transaction, Clinigence Health, a subsidiary of Clinigence Holdings, transferred certain of its intellectual property (IP) assets and patents, and liabilities of roughly $3.2 million, to AHA for an aggregate purchase price of $15 million of Preferred Stock of AHA.

Clinigence Holdings, Inc. (CLNH), closed Thursday's trading session at $1.90, even for the day, on 1,057 volume with 7 trades. The average volume for the last 3 months is 1,082 and the stock's 52-week low/high is $0.970000028/$3.45000004.

chart

Corvus Gold, Inc. (CORVF)

NetworkNewsWire, SmallCapPower, Zacks, Research Pool, InvestorsHub, Trading View, The Prospector News, Investing News, Stockhouse, Morningstar, Simply Wall St, The Daily Gold, MineStat, Street Insider, GuruFocus, Real Investment Advice, Wallet Investor, Junior Mining Network, Stock News Now, Stock Digest, Proactive Investors, and Investors Hangout reported previously on Corvus Gold, Inc. (CORVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Corvus Gold, Inc. acquires, explores, and develops mineral properties primarily in the United States. Its mandate is to become a leading exploration and development company with the ultimate goal of becoming a non-operating gold producer with significant carried interest and royalty exposure. The Company’s principal mineral property is the North Bullfrog Project. This is a gold-silver mining project in northwestern Nye County, Nevada. Corvus Gold is based in Vancouver, British Columbia and the Company lists on the OTC Markets’ OTCQX.

The North Bullfrog Project consists of leased, patented, and unpatented mining claims covering an area of about 86.6 km2. This comprises a mix of private mineral leases of patented federal mining claims and 1,057 federal unpatented mining claims.

The Project is 10 km north of Beatty, Nevada, and 8 km north of the Bullfrog Mine previously operated by Barrick Gold Corporation. The North Bullfrog Project represents a large, low-sulphidation, epithermal bulk-tonnage gold system hosted in volcanic and sedimentary rocks. The project is 100 percent controlled by Corvus Gold.

Additionally, Corvus Gold has its Mother Lode Project. This Project is 165 km northwest of Las Vegas, Nevada, 10 km east of Beatty, Nevada, and around 20 road km’s from Corvus Gold’s North Bullfrog project in the Walker Land gold belt. The Mother Lode Project comprises 445 federal unpatented mining claims covering an area of approximately 36.5 km².

Last month, Corvus Gold announced it received results from the initial deep core hole from the Central Intrusive Zone “CIZ” target and discovered a large new gold mineralized zone below the known existing Mother Lode deposit. The new, large discovery below the Mother Lode Deposit is 125.5m @ 2.6 g/t Gold including 14.8m @ 8.9 g/t Gold & 24.7m @ 4.9 g/t Gold.

Mr. Jeffrey Pontius, President and Chief Executive Officer of Corvus Gold, said, “These new results now reveal the potential of the CIZ. We will be evaluating this exciting target with our ongoing innovative core drilling program at Mother Lode. In addition to the ongoing exploration work that is expanding the Mother Lode deposit, development work is also rapidly progressing on our low-Capex, quick to account, Phase1 starter project at North Bullfrog.”

Corvus Gold has started geophysical surveys throughout the Mother Lode trend to integrate district scale data into its belt-wide exploration models. The significantly expanded survey and other continuing regional studies and data compilations are designed to unlock the considerable potential effectively and efficiently for new discoveries across the belt and throughout the greater Bullfrog Gold District.

Corvus Gold, Inc. (CORVF), closed Thursday's trading session at $2.24, up 1.2841%, on 36,239 volume with 58 trades. The average volume for the last 3 months is 86,139 and the stock's 52-week low/high is $0.715269982/$2.51999998.

chart

Fosterville South Exploration Ltd. (FSXLF)

Mining Stock Education, Junior Mining Network, MarketWatch, News Break, OTC Markets, Invezz.com, Barchart, TradingView, Nasdaq, King World News, InvestorX, GlobeNewswire, Ceo.ca, Stockhouse, Dividend.com, GuruFocus, Stockwatch, Seeking Alpha, and PR Newswire reported earlier on Fosterville South Exploration Ltd. (FSXLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A junior exploration enterprise, Fosterville South Exploration Ltd. engages in the acquisition and exploration of epizonal orogenic gold deposits in Australia. The Company has two large, 100 percent owned, high-grade epizonal gold projects named the Lauriston and Golden Mountain Projects and one large group of tenement applications named the Providence Project in the State of Victoria, Australia. This includes a 600 sq. km property immediately to the south of and within the same geological framework that hosts Kirkland Lake Gold's Fosterville tenements. Fosterville South Exploration has its corporate office in Vancouver, British Columbia.

Furthermore, the Company recently acquired three gold-focused projects named the Moormbool, Timor, and Avoca Projects that are also situated in the State of Victoria, Australia. Additionally, Fosterville South holds tenement applications over the prolific Walhalla Belt Project. Six of its properties (Lauriston, Providence, Golden Mountain, Walhalla, Timor, and Avoca) have had historical gold production from hard rock sources despite limited contemporary exploration and drilling.

The Lauriston Gold Project is an epizonal gold-antimony-arsenic mineralized project. It has the best potential to be the southern extension of the Fosterville Goldfield Belt, outside of Kirkland Lake’s extensive tenements.

The Providence Gold Project is a large tenement application (650 km²) amalgamating the Luckie Reef at Alexandra, Reedy Creek, and Yea tenements. The Golden Mountain Project Exploration Licence (EL6430) was applied for in early 2017 encompassing 136 km² in Victoria and was granted on May 8, 2018 for 2 years with optional extensions to 5 years.

In May, Fosterville South Exploration announced that it expanded its portfolio of high quality gold projects with the consolidation and acquisition of the 547 square kilometer Walhalla Belt Project in Victoria, Australia. Total recorded historic hard rock gold production from the project is 1,510,309 ounces of gold at a recovered grade of 33.59 g/t gold. This Project has dozens of high priority exploration targets including former mines, most with no modern drilling.

Fosterville South Exploration has retained Mining One Pty. Ltd. of Melbourne, Australia for the Walhalla Belt Project, positioned in the highly prospective Walhalla – Woods Point Belt, Victoria, Australia. Mining One is an employee owned, independent group of more than 65 technical consultants with offices in Melbourne (Head Office), Jakarta, Perth, Adelaide, Brisbane, Beijing, Vancouver, and Toronto. Walhalla Belt Project exploration potential includes targeting the identification of new mineralized shoots at Cohen's Reef and repeating structures.

Fosterville South Exploration Ltd. (FSXLF), closed Thursday's trading session at $1.93913, up 9.5554%, on 71,467 volume with 144 trades. The average volume for the last 3 months is 81,828 and the stock's 52-week low/high is $0.945399999/$2.00379991.

chart

WildBrain Ltd. (WLDBF)

Market Screener, OTC Markets, Dividend Investor, Morningstar, GuruFocus, Dividend.com, ETFChannel.com, MarketBeat, News Break, Stockhouse, Nasdaq, TradingView, MarketWatch, Seeking Alpha, Barchart, Street Insider, PR Newswire, Newsday, and Newswire.ca reported earlier on WildBrain Ltd. (WLDBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

WildBrain Ltd. is a worldwide leader in kids and family entertainment. It has about 13,000 half-hours of filmed entertainment in its library. The Company’s shows are seen in greater than 150 countries on over 500 telecasters and streaming platforms. The Company was previously known as DHX Media Ltd. It changed its name to WildBrain Ltd. in December of 2019. Incorporated in 2004, WildBrain has its head office in Halifax, Nova Scotia. The Company also has offices internationally.

WildBrain is home to brands including Peanuts, Teletubbies, Strawberry Shortcake, Caillou, Inspector Gadget, Johnny Test, and Degrassi. Its AVOD business - WildBrain Spark - offers one of the largest networks of kids' channels on YouTube, with more than 168 million subscribers. WildBrain Spark builds brands via the management and creation of preschool and children’s entertainment content on platforms such as YouTube, Amazon Video Direct, as well as ROKU.

In addition, the Company licenses consumer products and location-based entertainment in every major territory for its own properties and also for its clients and content partners. WildBrain’s television group owns and operates four family entertainment channels that are among the most viewed in Canada.

WildBrain Studios works with global partners including Apple, Netflix, LEGO, DreamWorks, BBC, Cartoon Network, Nickelodeon and more. It develops and produces original animated and live-action series for audiences from preschoolers to teens.

WildBrain Television consists of Family Channel, Family CHRGD, Family Jr., and Télémagino. WildBrain Television is home to world-renowned series including America Ninja Warrior Jr., Miraculous: Tales of Ladybug and Cat Noir, Just Add Magic and Chip and Potato.

WildBrain’s distribution team is in Toronto, Paris, and Beijing. It manages linear and non-linear rights on a territory-by-territory basis. It services a worldwide roster of up to 40 unique clients monthly. It delivers more than 3,000 digital files monthly.

Recently, WildBrain reported its Fiscal 2020 Q3 2020 and nine-month (YTD 2020) results for the periods ended March 31, 2020. Revenue was $98.3 million in Q3 2020 versus $110.0 million in Q3 2019. YTD 2020 revenue was $332.7 million versus $331.0 million YTD 2019.

Net Loss was $221.7 million, due mainly to a non-cash goodwill impairment of $184.5 million in the quarter, versus a Net Loss of $18.4 million in Q3 2019. YTD 2020 Net Loss was $240.0 million versus a Net Loss of $38.7 million YTD 2019.

WildBrain Ltd. (WLDBF), closed Thursday's trading session at $1.128461, up 8.5059%, on 377,439 volume with 767 trades. The average volume for the last 3 months is 48,593 and the stock's 52-week low/high is $0.480100005/$1.75020003.

chart

One Step Vending Corp. (KOSK)

Investor Village, Spotlight Growth, Simply Wall Street, Morningstar, Barchart, OTC.Watch, Emerging Growth, GuruFocus, TipRanks, YCharts, Journal Transcript, Insider Financial, Nasdaq, Stockhouse, Investing.com, OTC Markets, Wallet Investor, Market Screener, Stockwatch, New Media Wire, Dividend Investor, InvestorsHub and GlobeNewswire reported earlier on One Step Vending Corp. (KOSK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

One Step Vending Corp. is a holding company centered on the acquisition of market-changing and disruptive business models. It grows via acquisitions and cooperative agreements with companies that have high potential and capabilities of attaining sustainable growth, resulting in a rapidly acquiring market share. Established in 2004, the Company previously went by the name Rewards Nexus, Inc. It changed its name to One Step Vending Corp. in March of 2015. The Company is registered in Carson City, Nevada.

At present, One Step Vending targets the food and refreshments services, self-checkout systems, and mobile vending sectors. The Company builds important strategies for it subsidiaries while providing financing and operational business support.

One Step Vending has its CBD (cannabidiol) Kiosks. Sofos CBD, Inc., is developing the www.cbdkiosks.com offering. This is an online platform of selected, unique and high-quality hemp products from the leading American brands of innovative producers and manufacturers in the cannabidiols industry.

Sofos CBD, Inc., is a wholly owned subsidiary of One Stop Vending. One Stop supports subsidiaries, such as Sofos CBD with key financial, sales, marketing, and operational changes designed to speed up growth and shareholder value.

This e-shop’s emphasis is offering CBD based and infused products. This includes capsules, edibles, drinks, body care and wellness products. In addition, the platform will offer to One Step Vending’s merchant/suppliers direct access to a dashboard that they will be able to upload their products upon approval.

Featured products of Sofos CBD include Lawrence Taylor Pain Master CBD Cream, Chill Plus Gummies, Strawberry Flavor Diamond CBD OIL, Blue CBD Crystals Isolate, and Chill CBD Shot. Featured products of Sofos CBD also include Biotech CBD Cream, Chong’s Choice CBD, as well as Diamond CBD Full Spectrum Vape.

Fundamentally, Sofos CBD is developing a wholesale network with stores in order to supply CBD infused products for consumers. Furthermore, it has formed strategic partnerships with certain suppliers to distribute their products.

One Step Vending Corp. (KOSK), closed Thursday's trading session at $0.0055, up 57.1429%, on 30,977,624 volume with 294 trades. The average volume for the last 3 months is 1,730,766 and the stock's 52-week low/high is $0.002249999/$0.014.

chart

BioHemp International, Inc. (BKIT)

Wall Street Reporter, TipRanks, Micro Small Cap, Wall Street Newscast, OTC Markets, Simply Wall St, Stockwatch, IssueWire, Morningstar, Street Insider, Investing News, GlobeNewswire, OTC Markets Research, Stockhouse, InvestorsHub, and TradingView reported previously on BioHemp International, Inc. (BKIT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioHemp International, Inc. concentrates on rolling up a distribution platform for CBD (cannabidiol) providers to become the foremost consolidation force in the CBD industry. The Company is centering on establishing a presence in the fast growing consumer hemp and CBD market. It is looking to capitalize and leverage the public markets to attain market share via consolidation to become the market leader in the growing CBD sector.

Formed in 2012, BioHemp International lists on the OTC Markets and the Company is based in New York, New York. It previously went by the name Blake Insomnia Therapeutics, Inc. It changed its corporate name to BioHemp International, Inc. in June of this year.

BioHemp International’s formula is to create a platform, which will combine equity and capital to facilitate acquisitions of premium branded product that will be managed by a team of people with wide-ranging industry expertise.

Recently, BioHemp International announced that it appointed American Premium Water Corporation (HIPH) Chief Executive Officer (CEO), Mr. Ryan Fishoff as Lead Advisor to the Company. Mr. Fishoff will assist Company CEO, Mr. Daniel Blum, with M&A (Mergers & Acquisitions) Strategy and CBD industry knowledge as the Company begins its consolidation rollup strategy.

Mr. Fishoff has a distinguished resumé in the public markets, having been CEO of American Premium Water for close to two years. He brings comprehensive knowledge of the CBD industry, as he has led American Premium Water to become one of the foremost manufacturers and marketers of consumer CBD products in the industry.

Recently, American Premium Water Corporation (HIPH) announced that it agreed to a deal that will imminently be executed allowing BioHemp International (BKIT) to license its proprietary Hydro Nano technology to be used to manufacture water and other CBD infused beverages across BKIT’s present and future platforms. Its Hydro Nano formulation uses proprietary nanotechnology that decreases the size of the majority of the CBD molecules encapsulated to one nanometer or less in diameter.

BioHemp International, Inc. (BKIT), closed Thursday's trading session at $0.05, up 233.3333%, on 50,484 volume with 6 trades. The average volume for the last 3 months is 700 and the stock's 52-week low/high is $0.001099999/$4.00.

chart

Artemis Therapeutics, Inc. (ATMS)

NetworkNewsWire, Stock Digest, Last10k, GuruFocus, MarketWatch, Zacks, Wallmine, OTC Markets, Penny Stock Tweets, 4-Traders, YCharts, Stockhouse, InvestorsHub, NASDAQ.com, Simply Wall St, Financial Content, Morningstar, and Barchart reported previously on Artemis Therapeutics, Inc. (ATMS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Artemis Therapeutics, Inc. centers on the development of new therapies for the treatment and prevention of severe and life-threatening infectious diseases. The Company’s lead product candidate is Artemisone. This is a unique, synthetic artemisinin derivative with potent anti-viral and anti-parasitic properties. A clinical-stage biopharmaceutical company and OTCQB listed, Artemis Therapeutics is headquartered in New York, New York.

Artemisone is a best-in-class artemisinin. It has been studied in a Phase 2 clinical trial for the treatment of malaria (p. falciparum). The Company has licensed pre-clinical data from Hadasit Medical Research Services and Development Ltd. in HCMV and clinical data from Hong Kong University of Science and Technology R and D Corporation Limited (RDC) in the treatment of Malaria.

Artemisinin and its derivatives, including artesunate, artemether, arteeter and dihydro-atemisinin (DHA), have for numerous years been the foundation of treatment of uncomplicated p. falciparum malaria. Phase II clinical data has shown Artemisone to be an effective treatment for p. falciparum malaria infection when dosed over a 2-day or 3-day course, alike to or shorter than other available malaria treatments.

At present, Artemisone is undergoing in vitro evaluation for its activity against human cytomegalovirus (CMV). This includes transplant CMV and congenital CMV. Artemis announced in June of 2018 that new data on its lead product candidate Artemisone shows it is a potent inhibitor of human cytomegalovirus (HCMV) replication in preclinical assays. The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Artemisone for the treatment of malaria.

Artemisone in a preclinical setting is a potent inhibitor of human cytomegalovirus (HCMV) replication and the transmissible stages of malaria. Human cytomegalovirus (CMV) is a common virus related to the viruses that cause chickenpox, herpes simplex, as well as mononucleosis. CMV is transmitted via bodily fluids. Artemis Therapeutics’ lead product candidate, Artemisone, is undergoing development as a best-in-class treatment for malaria and first-in-class treatment for CMV.

Artemis Therapeutics, Inc. (ATMS), closed Thursday's trading session at $0.20, up 469.8006%, on 685 volume with 10 trades. The average volume for the last 3 months is 4,246 and the stock's 52-week low/high is $0.032000001/$0.449999988.

chart

First Foods Group, Inc. (FIFG)

Stockwolf, Stockwatch, Wall-St, OTC Markets, Real Investment Advice, Investors Hangout, The Street, Market Screener, TradingView, Stockhouse, Penny Stock Hub, Euro Investor, YCharts, and MarketWatch reported on First Foods Group, Inc. (FIFG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

First Foods Group, Inc. has growing interests in the food and food service industry. The Company provides management services and financing options for new foodservice brands and menu concepts. Moreover, it is growing its new concepts through proprietary development and through mergers, acquisitions, and licensing arrangements. The Company formerly went by the name Litera Group, Inc. It changed its name to First Foods Group, Inc. in February 2017. First Foods Group has its head office in Las Vegas, Nevada.

First Foods Funding invests in short-term merchant cash advances that have been producing immediate high rates of return on capital. This Division continues to realize fast growth through the reinvestment of its profits while attracting substantial new funds from outside investors.

First Foods earlier signed cannabis business expert Mr. Robert Hunt, Esq. to identify opportunities in the legal cannabis industry where the Company’s management, expertise, and relationships could have considerable effect. Mr. Hunt is one of the distinguished consultants in the legalized marijuana industry. He has been instrumental in many of the best known and most successful cannabis businesses in operation today.

First Foods Group entered into a binding term sheet in April 2017 with globally renowned chocolatier and entrepreneur Mr. Oded Brenner. This is to fully develop Mr. Brenner’s new chocolate-based retail concept. The venture is jointly owned by First Foods Group and Mr. Brenner. Initial plans are to launch two flagship stores in New York, New York, and to immediately take advantage of numerous multi-unit global franchising opportunities.

Holy Cacao is marketing premium chocolate products created and packaged by Holy Cacao consultant, Mr. Oded Brenner, founder of "Max Brenner, Chocolate by the Bald Man," for the legal cannabis sector. Mr. Brenner has incorporated an exotic mix of champagnes, sherries, and select cannabis strains into his chocolate formulas.

First Foods Group registered its Holy Cacao® subsidiary with the State of Nevada on August 31, 2017. The Company stated that Holy Cacao will soon be licensed as a THC product in the legal marijuana states.

First Foods Group recently reported GAAP Revenue of $85,510 for the second fiscal quarter of 2018. This represents an increase of 42 percent over the GAAP Revenue of $60,295 reported for the first fiscal quarter of 2018. The Company’s financial results are supporting the expansion of its Holy Cacao subsidiary. This subsidiary is finalizing negotiations to produce high-end chocolate, which will be sold and distributed to the edibles market using First Foods’ trademarked brand and packaging.

First Foods Group, Inc. (FIFG), closed Thursday's trading session at $0.195, up 95.00%, on 500 volume with 1 trade. The average volume for the last 3 months is 6,025 and the stock's 52-week low/high is $0.100000001/$0.600000023.

chart

Lot78, Inc. (LOTE)

Promotion Stock Secrets, Street Register, OTC Markets, Emerging Growth, Aim High Profits, Insider Financial, Penny Stock Tweets, Stockwatch, Penny Stock Dream, Hotstocked, and Predict Wall Street reported on Lot78, Inc. (LOTE), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Lot78, Inc. designs, markets, distributes and sells apparel under the Lot78 brand name. It operates in three segments: Wholesale, Consumer Direct, and Core Services. Ollie Amhurst is the Founder and Creative Director of the Company. From the start, the business strategy was to build Lot78 into a men’s and women’s ready to wear line. Lot78 has its head office in London, England.

The Company was incorporated in Nevada on June 27, 2008. On March 14, 2011, it filed a Certificate of Amendment with the Secretary of State of Nevada changing the name of the Company to "Bold Energy, Inc."

On November 12, 2012, the Company, then under the name Bold Energy, entered into a Share Exchange Agreement with Anio Limited a limited liability company formed under the laws of the United Kingdom (Anio Ltd.) that conducts its main line of business under the name Lot78, Inc., the shareholders of Anio Ltd., and the controlling stockholders of the Company.

On January 31, 2013, it changed names to Lot78, Inc. On July 15, 2016, the Company entered into a Letter of Intent (LOI) to merge with Compound Holdings, LLC, a Connecticut limited liability company. Then, on July 18, 2016, the Company and Compound Holdings LLC entered into a definitive Agreement and Plan of Merger. With this plan of merger, upon closing, its intention is to change its name to Compound Holdings, Inc.

Lot78 offers a collection of men's and women's ready to wear line that includes leather jackets, T-shirts, sweats, knitwear, accessories, jeans, chinos, and wool coats. The Company sells its products to department stores, specialty retailers, and boutiques. In addition, it sells its products via lot78.com.

In October of 2017, Lot78 announced that it was scheduled to acquire a 2.5 percent equity stake in Garage Juice Bar, LLC also known as Juice Bar Electric Vehicle Charging Stations. Lot78 stated that this investment aligns with the Company’s mission to provide value to shareholders via the acquisition of investments, which show potential to be scaled regionally and/or nationally or investments that drive outsized returns.

Lot78, Inc. (LOTE), closed Thursday's trading session at $0.0058, up 65.7143%, on 34,240 volume with 6 trades. The average volume for the last 3 months is 46,127 and the stock's 52-week low/high is $0.001599999/$0.0269.

chart

Prism Technologies Group, Inc. (PRZM)

Zacks, Wall Street Journal, TradingView, MarketWatch, and InvestorsHub reported on Prism Technologies Group, Inc. (PRZM), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Prism Technologies Group, Inc. is an intellectual property (IP) licensing and technology research & development  (R&D)  company. The Company, by way of its wholly-owned subsidiaries, owns a patent portfolio consisting of nine patent families incorporating 61 issued and six pending patents in the Computer & Network Security, Semiconductors, and Medical Technology arena.

Established in 1995, Prism Technologies Group is the parent company of Prism Technologies, LLC, which is a Nebraska Limited Liability Company (LLC) based in Omaha, Nebraska. Prism Technologies Group has its corporate office in Folsom, California.

The Company previously went by the name Internet Patents Corporation. It changed its name to Prism Technologies Group, Inc. in September of 2015. The Company lists on the OTC Markets Group’s OTCQB.

Prism Technologies Group licenses and enforces a portfolio of patents relating to its technologies. It continues to develop and patent new technologies.

The Company’s dedication is to continuing R&D efforts in a number of fields. Its mission is to continue to develop and invent new technologies in computer and network security, wearable computing, transaction processing,  and healthcare to speed up time to market opportunities for its clients.

Prism Technologies Group’s Executive Team includes Mr. Hussein A. Enan - Chairman, Chief Executive Officer; and Mr. Greg Duman - President, Prism Technologies, LLC and member of Prism Group's Board of Directors. Mr. Duman chairs the Audit Committee. Prism Technologies Group announced in October of 2017 that it entered into an Asset Purchase Agreement with Amorphous Technologies International (ATI). ATI is a leader in the development of innovative amorphous alloy solutions based on proprietary materials technology. Its solutions deliver value through removing the limits of existing materials technology, which result in high costs throughout the lifecycle of a product.

The Agreement is to acquire certain intellectual property (IP) assets related to unique uses for amorphous metals.  After the close of the transaction, Prism will commercialize the acquired IP assets to create new amorphous metal technology offerings for the consumer electronics, automotive, industrial, and other business sectors.

Prism Technologies Group, Inc. (PRZM), closed Thursday's trading session at $0.0469, up 160.5556%, on 1,800 volume with 1 trade. The average volume for the last 3 months is 742 and the stock's 52-week low/high is $0.014999999/$0.096.

chart

StartMonday Technology Corp. (STMDF)

Dividend Investor, OTC Markets, Stockhouse, MarketWatch, Barchart, GuruFocus, Science of Stocks, Investorx.ca, and Penny Stock Hub reported on StartMonday Technology Corp.  (STMDF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

StartMonday Technology Corp. engages in candidate selection solutions for employers in the retail and hospitality sectors. The Company helps employers choose better candidates, quicker, with the power of 15-second video introductions. A smart recruitment technology enterprise, StartMonday Technology has its corporate headquarters in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

StartMonday Technology was founded by professionals from the recruiting and tech fields - Ray Gibson from recruiting and HR, and Andrew Evans from the founding team at Careerbuilder.com.

StartMonday Technology’s commitment is to building strong tools for the Mobile Generation. Moreover, the Company is further developing its technology with an open blockchain solution for verifiable career histories named CareerChain.

StartMonday's video-led mobile and web applications deliver a better impression of customer skills and personality, ultimately assisting employers in deciding which candidates they should talk to first. This makes the process much more efficient.

StartMonday's core products center around 15-second videos filmed by candidates on their own mobile phones and web browsers. This puts job applications decisively in the social media and mobile native arena.

This enables job seekers to present themselves in their own way. In addition to lessening cost and time-to-hire, the Company brings massive employer branding opportunities to its clients.

Recently, StartMonday Technology announced that it has partnered with Talent Tech Labs (TTL)- Manhattan-based, as part of their late-stage accelerator program targeted at advancing select, mature startups ready for targeted penetration into the North American market. Talent Tech Labs is a sector leader in the knowledge and analysis of up-and-coming trends and technologies applied to improving the state of the art of recruitment.

StartMonday Co-Founder and Chief Executive Officer, Mr. Ray Gibson said, “We are extremely pleased to have been selected for the TTL accelerator program. This is a limited and very influential opportunity that has previously proven its worth at propelling entry into the U.S. marketplace… We believe this program will ideally position us to really show what StartMonday and CareerChain can do to accelerate success within the HR industry arm of Corporate America.”

StartMonday Technology Corp. (STMDF), closed Thursday's trading session at $0.01995, up 227.0492%, on 300 volume with 3 trades. The average volume for the last 3 months is 469 and the stock's 52-week low/high is $0.003599999/$0.143000006.

chart

The QualityStocks Company Corner

Vivos Therapeutics Inc.

The QualityStocks Daily Newsletter would like to spotlight Vivos Therapeutics Inc..

Headquartered in Denver, Colorado, Vivos Therapeutics Inc. is an emerging global leader in the treatment of obstructive sleep apnea (OSA), a debilitating condition affecting nearly 1 billion people worldwide. The company utilizes proprietary, ground-breaking technology, a proven go-to-market strategy, and a powerful executive team dedicated to changing the face of health care by helping people of all ages properly breathe and sleep.

At the core of Vivos’ mission to eradicate OSA is the Vivos System®, a revolutionary clinical breakthrough in the treatment of sleep apnea caused by craniofacial anatomy development. The Vivos System® multidisciplinary treatment protocol involves collaboration between physicians, specially-trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary health care providers.

In support of its growth strategy, Vivos has established FDA-approved and registered manufacturing facilities in the U.S., Canada and Asia.

Market & Technology Overview

Craniofacial developmental deficiencies, such as underdeveloped upper and lower jaws, are the leading cause of OSA. According to a 2019 analysis from researchers at the University of California, San Diego, an estimated 81 million adults in North and South America suffer from moderate to severe OSA. The United States has the highest amount of these patients, with approximately 54 million adults affected, according to the report.

Registered with the FDA as a Specification Developer, Vivos develops and markets a number of oral appliances. Its technology represents the first non-surgical, non-invasive and cost-effective solution for the estimated hundreds of millions of people globally who suffer from OSA.

Vivos integrates its specially designed, customized appliances into a patient-specific, multi-disciplinary clinical protocol, giving trained dental and medical providers the tools and roadmap needed to address certain craniofacial conditions that have proven to be associated with sleep-disordered breathing—including OSA.

The system’s treatment protocol involves collaboration between physicians, specially trained dentists who have received advanced training in craniofacial sleep medicine, and additional health care providers. Vivos-trained clinicians can be found in almost every major city in the U.S. and in many countries throughout the world. The company’s oral appliances have shown to be effective in over 15,000 patients successfully treated worldwide by approximately 1,350 trained dentists.

A New Paradigm in Sleep Medicine

Vivos’ proprietary system poses the potential to be the biggest breakthrough in OSA treatment since CPAP.

Designed to promote correct growth and development of the hard and soft tissues surrounding and compromising the oral cavity, nasal cavity, upper and lower jaws, and other tissues which comprise and shape the human airway. The system uses Pneumopedics®, the natural process induced by Vivos biomimetic technology to widen and expand the patient’s airway, allowing for proper breathing through the nose, effectively addressing the root cause of OSA.

This patented technology offers benefits over CPAP and other oral appliances in its ability to achieve results relatively quickly—in about 18 to 24 months or less—at a lower cost, and without the need for lifetime intervention in most patients. It is believed to be the first effective, non-surgical, non-invasive and potentially long-lasting solution to eradicating OSA.


Biomimetic Oral Appliance

A treatment protocol that targets the underlying cause of sleep apnea.

The Vivos System® works to treat the root cause of OSA by non-surgically remodeling and repositioning the hard and soft tissues that compromise the human airway.

The Vivos System® treatment is typically less than $10,000 and is covered by most major health plans.

A potentially serious medical problem with a solution in the dental office.

Hard and soft tissues of the craniofacial complex can be non-surgically remodeled and enhanced using the proprietary Vivos® System devices and clinical protocols.


Strategic Partnership

A cooperative agreement with Benco Dental, the largest family-owned dental distributor in the United States, broadens the reach of the Vivo System. This partnership ensures that all dentists in the United States have access to Vivo’s patented system, on par with Vivo’s vision to provide clinicians with the tools to provide the best alternative solution to treat OSA and well-aligned with Benco’s commitment to evolve the dentistry industry by empowering clinicians with innovative treatment options.

Leadership

R. Kirk Huntsman – CEO, Director
With experience in strategic development, technology acquisition and product planning, key talent recruitment, and target market prioritization, Huntsman brings a broad vision paired with leadership and strategic planning skills. He has significant start-up experience in a diverse range of market sectors, including medical devices, dental management, dental practice valuations and transitions, multi-location retail, financial and capital formation, consulting, outsourced services, imports and exports (China), medical services, and software and technology.

Dr. Dave Singh – Founder, Director
A doctor three times over in dental medicine, craniofacial development, and orthodontics, Dr. Singh was educated primarily in England and has lectured in North America, Europe, Asia, and Africa. The Global Summits Institute recently named Dr. Singh as one of the Top 100 Doctors in Dentistry.


Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its receipt of an order for the 12th and final system scheduled to be built in the Company's initial manufacturing run of its revolutionary BaroShear(TM) K45 processing system. To view the full press release, visit http://nnw.fm/lBWN8. Also today, the company was highlighted in a publication from FinancialNewsMedia.com, examining how, according to an article by the National Cannabis Industry Association, Nanoemulsions will have an impact in the medicinal, beverage and infused markets in the coming months and years. Consumers and manufacturers of products that have been infused with THC or CBD are probably very familiar with two key issues that plague the product class: slow onset time and uneven dosing of the active ingredient. In a bid to provide a solution, many groups are marketing "water-soluble technology," or "nanotechnology."

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Thursday's trading session at $2.47, up 7.8603%, on 27,066 volume with 75 trades. The average volume for the last 3 months is 15,968 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX) recently held its FY 2019 and Q1 2020 results conference call (http://nnw.fm/JRe52). To view the full article, visit http://nnw.fm/2tySk

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Thursday's trading session at $2.0199, up 10.377%, on 89,633 volume with 282 trades. The average volume for the last 3 months is 56,368 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

chart

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

The automotive industry market has been in a state of flux, with every aspect experiencing disruption from driverless vehicles to artificial intelligence. Customer expectations for the market have been raised as technological innovation advances. Digitally savvy customers, who have come to expect personalized, flexible and seamless interactions during the purchase experience, are already changing how automobiles are bought and sold – especially when it comes to used vehicles. Platforms like PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) meet this growing demand for flexible and seamless interaction, enabling users to buy or sell cars with never-seen-before ease and efficiency.

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Thursday's trading session at $0.147, up 5.7554%, on 147,600 volume with 16 trades. The average volume for the last 3 months is 44,228 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD), together with its BudCars Cannabis Delivery Service (“BudCars”), today announced record growth data for BudCars sales during the month of May. According to the update, the company posted nearly 30% sequential monthly growth over April sales and continues to see week-over-week sales growth at 10%, which suggests that BudCars will surpass $10 million in annualized sales by the month of August at its Sacramento location. To view the full press release, visit http://cnw.fm/Rnr9N

Sugarmade, Inc. (SGMD) is headquartered in Monrovia, California, where the company recognizes new opportunities in the cannabis delivery space and in the market for supplies to the quick-service restaurant industry – both of which have fast-changing dynamics due to the recent outbreak of coronavirus in the United States.

The Coronavirus Cannabis Boom Market

Retailers across the nation are closing their doors and curtailing operations due to the coronavirus pandemic, inherently pinching sales. In the California cannabis sector, however, business has never been better – especially relative to home delivery.

California’s cannabis industry continues to operate, and media reports reveal booming cannabis sales as the state’s citizens stay home to wait out current events. The Los Angeles Times recently published the headline, “Marijuana Sales on Fire amid Virus Outbreak; New York Post “Cannabis sales hit new highs”; USA Today “American Stock Up on Pot” Fox News “California marijuana sales surge”; and ABC News Cannabis Shops thrive in coronavirus pandemic.

The state of California benefits from the ultra-high taxes paid by the highly regulated cannabis industry, and has thus deemed cannabis companies as “essential” businesses, allowing for full operations to continue. While pot shops are seeing strong foot traffic, the real growth action is in-home delivery as consumers seek to embrace social distancing. Many delivery operators are reporting difficulty in meeting demand with sales growth of up to 10% sequentially each week. It is certainly a boom time for the industry.

Sugarmade Growth Strategy

Recognizing new investment and operational opportunities within California’s cannabis market, Sugarmade is strategizing to take advantage of opportunity specifically in delivery services (non-storefront retailer), manufacturing via co-branding, and selective genetic cultivation. The company is taking a highly selective approach, targeting only the best of these opportunities for company growth.

In line with this strategy is northern California delivery service Budcars, in which Sugarmade owns a 40% interest and an option to gain a controlling interest. Budcars connects consumers with premium products sourced from top-tier farms and extractors, offering a curated menu of fully compliant cannabis products. The company maintains a competitive advantage by sourcing premium cannabis offerings and same-day delivery. In addition to maintaining its own cars, California licenses, and fulfillment center, Budcar orders its premium products in bulk at lower prices, enabling the company to rein in costs and maintain competitive pricing for its customers. Currently serving major communities within the metropolitan area of Sacramento, Budcars plans to continue the expansion of the company’s delivery reach.

Sugarmade plans to continue its expansion into burgeoning new sectors of the cannabis market through the following avenues:

  • Geographic expansion of Budcars delivery scope
  • New delivery geographies
  • Cannabis cultivation as a key component of a hybrid vertical integration strategy
  • Product technology expansion—including products containing exotic and lesser-known cannabinoids

 

Diversified Portfolio

Sugarmade has positive market exposure to cannabis delivery, as well as to the restaurant industry, at a time when these businesses are being force to move toward take-out and delivery models in order to survive.

The company has various business operations in diverse marketplaces, including food, safe packaging and sanitary supplies for various industries, and agricultural supplies. Sugarmade entered the industrial hemp and CBD space by investing in Hempistry, Inc., a privately held Nevada corporation. Hempistry began planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 5,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3% of THC, the psychoactive ingredient found in cannabis.

CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high-quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30%-40% of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Market Opportunity

There is little doubt among industry participants, and recently confirmed by Forbes, that California is the single largest cannabis market in the world. The state is expected to produce more than $3.5 billion in cannabis sales during 2020, with growth topping 23% annually. The global industrial hemp market size was estimated at $4.71 billion in 2019 and is expected to register a revenue-based CAGR of 15.8% over the forecast period of 2016-2027, according to Grandview Research. Market growth drivers include the 2018 Farm Bill and society’s increasing knowledge of the benefits of hemp products.

Overall industry growth is great, but specific vertical sector growth is even better. Cannabis delivery is clearly the fastest growing sector of the marketplace and with coronavirus fears the already robust growth rate has accelerated.

Sugarmade seems to be in the right industry at the right time in history.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick-service restaurant industry, which merged with Sugarmade in 2014.

Dedicated to getting the highest caliber of THC and CBD to its customers’ door, the company’s priority is to ensure that they receive the highest quality cannabis product free from logistical hassles. Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed Thursday's trading session at $0.0019, up 5.5556%, on 88,901,836 volume with 688 trades. The average volume for the last 3 months is 25,209,558 and the stock's 52-week low/high is $0.0017/$0.050500001.

Recent News

chart

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Stellar results recently reported by Trxade Group Inc. (NASDAQ: MEDS) are an indication that, increasingly, independent pharmacies, drug distributors and manufacturers are turning to the company’s web-based purchasing platform. At $2.2 million, revenues for Q1 2020 were up 46% year over year, with gross profit coming in at an extraordinary 74.4%. Now that more than 11,900 pharmacies are using the marketplace, Trxade seems set to fulfil its mission of signing most of the nation’s 24,000 independent pharmacies. If so, the company’s combined annual purchasing power of over $92 billion would make Trxade the nation’s premier marketplace for America’s vital pharmaceutical supplies.

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Thursday's trading session at $5.69, up 1.07%, on 14,941 volume with 112 trades. The average volume for the last 3 months is 120,239 and the stock's 52-week low/high is $2.94000005/$11.6000003.

Recent News

chart

Kingman Minerals Ltd. (TSXV: KGS)

The QualityStocks Daily Newsletter would like to spotlight Kingman Minerals Ltd. (TSXV: KGS).

Canada-based Kingman Minerals (TSX.V: KGS) is engaged in the acquisition, exploration and development of gold and silver properties in North America. An article discussing the company further reads, “Kingman Minerals is focused on enhancing shareholder value as it continues exploring potential assets and acquiring strategic gold targets. The company recently commissioned mining consulting services company Burgex Mining Consultants Inc. to complete two underground gold-exploration programs in the historic Rosebud Mine. To view the full article, visit http://nnw.fm/yU9T9. Also today, NetworkNewsWire released a report on the company detailing how Gold’s historic reputation as a safe haven asset looks promising for mining companies as the global economy witnesses the volatile valuation of currency. Kingman Minerals Ltd. (TSX.V: KGS) (KGS Profile) has been preparing operations on a historic mine site in Arizona, benefiting from the cost efficiencies of revitalizing an already established exploration site.

Kingman Minerals Ltd. (TSXV: KGS), formerly Astorius Resources Ltd., is engaged in the acquisition, exploration and development of gold and silver properties in North America. The Canada-based company is focused on sourcing and developing high-quality properties in favorable mining locations to advance its diverse portfolio of low-cost, lifelong assets.

Kingman Mine

The Company maintains the following projects:

The Mohave Project: Located in the Music Mountains in Mohave County, Arizona. Approximately 35 miles from the town of Kingman, the property consists of 20 lode claims, including the historic Rosebud Mine. The Company has entered into an option agreement to earn 100% over four years. According to historic mappings of the mine, probable ore is 15,560 tons. Possible (inferred) ore is comprised of 176,000 tons, and additional possible (inferred) ore totals slightly over 1,100,000 tons. The total contained gold ounces for all categories is estimated at 664,000 ounces, and contained silver is estimated at 2,600,000 ounces. The Company has recently completed two underground reconnaissance and sampling programs and is in the process of verifying previous resource estimates.

 

The Cadillac East Property: Located approximately 55 kilometers east of Val d’Or, a hub for exploration and mining activities in the Canadian province of Quebec. The Company acquired a 100% interest in the property from an arm’s length vendor. Cadillac East Property consists of 12 claims, and the Company has an option agreement to earn 100% over three years. Having been the subject of numerous geophysical and geological surveys, the Cadillac East Property has been explored and surveyed by numerous companies as well as by the Quebec government. Exploration work done in 2017 by Exploration Facilitation Unlimited Inc. revealed multiple potential targets for future investigation, as results from the soil program identified value in gold, silver, copper, zinc and nickel.

Kingman Minerals is focused on enhancing shareholder value as it continues exploring potential assets and acquiring strategic gold targets. The company recently commissioned mining consulting services company Burgex Mining Consultants Inc. to complete two underground gold exploration programs in the historic Rosebud Mine. Burgex specializes in mineral exploration, mining claim staking, landman services, mining consulting, and the access and documentation of abandoned mine sites throughout the western United States and the world. Burgex’s founders have been active in the industry since 2007 and have identified, secured and consulted on hundreds of thousands of acres of mineral properties spanning a wide range of mineral commodities with billions of dollars’ worth of resources and reserves. The Burgex team has been featured in Forbes Magazine as well as on the Discovery Channel and other outlets. Burgex is at the vanguard of industry advancements in safely accessing difficult vertical abandoned mine workings and continues to pioneer new mineral exploration methods with strategic partners throughout the United States and the world.

Gold’s Predicted Rise

The value of gold is currently on an upward climb due to COVID-19’s upending of the global economy, causing governments to expand their balance sheets. In 2019, as a result of the housing and financial crisis, gold saw its best performance since 2010increasing as much as 20% and hitting a top price of $1,549 per ounce in September of that year. Analysts predict its price will continue to climb due to strong buying by central banks, a weakening of the U.S. dollar, and increasing political tensions. A recent Wolfe Research report predicted gold would hit an all-time high, referencing an ounce of gold that commanded a $1,515 asking price. As the value of the U.S. dollar weakens, the demand for gold is inversely rising. Known as a safe-haven asset, gold tends to see increased levels of demand during times of consumer fear or recession.

Management

Sandy MacDougall – Chairman and Director
An economics graduate from the University of British Columbia, Sandy MacDougall brings 30+ years of experience in the investment banking and finance industry to KGS. He was instrumental in the acquisition, development and production of gold at the Alto el Toro mine near Ibaguel, Columbia. As a former investment advisor at Canaccord Capital Corp., MacDougall was a key player in multiple significant financings in Canada as well as abroad, working with a wide range of companies. His experience has afforded him critical exposure to precious and base metal projects throughout North and South America, and he has served as chairman of the board since 2016.

Arthur Brown – President and Director
With 36 years of business experience and service to the boards of eight other companies in sectors ranging from technology to oil, gas and mineral exploration, Arthur Brown adds substantial knowledge in corporate structure and development as well as financings and venture capital to the KGS team.

Cyrus Driver – Independent Director
Cyrus Driver was a founding partner in the firm of Driver Anderson from its inception in 1982 and is a chartered accountant as well as a retired partner in the firm of Davidson and Company LLP. Aside from providing general public accounting services to a diverse range of clients, his specialty is servicing TSX Venture-listed companies and members of the brokerage community. With expert knowledge of the securities industry and its regulations, Driver lends valuable advice to his clients regarding finance, taxation and other accounting-related matters. He currently serves as director and chief financial officer of several TSX-V-listed companies.

Dr. Peter Born – Director and Technical Specialist
A professional geologist registered with the Association of Professional Geoscientists of Ontario and a fellow of the Geological Association of Canada, Dr. Peter Born brings 30+ years of experience in exploration and mining to the company. With prior roles as a senior geologist with Western Mining Corporation, he is currently working with RPS Energy Canada Ltd. on natural gas plays related to high-temperature dolomites and sedimentary zinc deposits (MVT) within the Appalachian Basin in the United States. Dr. Born holds a Ph.D. in earth sciences and has expertise in Precambrian sedimentary geology, basin analysis, sedimentology, stratigraphy and sedimentary ore deposits.

Kingman Minerals Ltd. (TSXV: KGS), closed Thursday's trading session at $0.155, off by 3.12%, on 21,500 volume with 6 trades. The average volume for the last 3 months is 33,415 and the stock's 52-week low/high is $0.09/$0.22.

Recent News

chart

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, is strategically positioned to capitalize on the Trump administration’s recently announced plan to revitalize the U.S. nuclear energy industry (http://nnw.fm/Hdi64). To view the full article, visit http://nnw.fm/06Dy1

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon-free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

 

Energy Fuels Inc. (UUUU), closed Thursday's trading session at $1.68, off by 1.7544%, on 802,082 volume with 2,438 trades. The average volume for the last 3 months is 1,628,771 and the stock's 52-week low/high is $0.779999971/$3.31999993.

Recent News

chart

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human-optimization sciences company with an emphasis on ketamine and psychedelic medicine, recently named Dr. Roger McIntyre as chief executive officer. To view the full article, visit http://cnw.fm/8TrHA. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Experts say we may be facing up to two years of intermittent lockdowns before the coronavirus is finally eradicated, and the economy will take even longer to spring back to pre-pandemic levels. At the moment, most regions in the U.S. are still under lockdown orders, and while this has helped reduce infections, the effect it has had on the economy has been catastrophic.

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRMF), closed Thursday's trading session at $0.89, off by 10.9555%, on 905,712 volume with 1,200 trades. The average volume for the last 3 months is 599,828 and the stock's 52-week low/high is $0.221/$1.74.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology Inc. (NASDAQ: POAI) is a knowledge-driven medicine company focused on applying data and artificial intelligence (AI) to cancer personalized medicine and drug discovery. In a recent interview (http://nnw.fm/o7Ysq), POAI director and CEO Dr. Carl Schwartz discussed the acquisition of two biological firms, along with details about the company’s proprietary Helomics database. Comprised of hundreds of thousands of tumors across numerous cancer types, this key asset gives the company a significant advantage over its competitors in the precision medicine industry.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Thursday's trading session at $1.61, off by 5.2941%, on 868,402 volume with 2,059 trades. The average volume for the last 3 months is 1,048,614 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced that it will present at the Virtual Investor Summit, slated to take place June 9-12, 2020. Sigma is scheduled to present at 11:30 a.m. Eastern Time on Wednesday, June 10, and its President and CEO Mark Ruport will host virtual one-on-one investor meetings throughout the event. Conference participation is by invitation only and registration is mandatory. To view the full press release, visit http://nnw.fm/jZj1a

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Thursday's trading session at $2.73, off by 3.537%, on 399,922 volume with 1,449 trades. The average volume for the last 3 months is 511,115 and the stock's 52-week low/high is $1.97000002/$17.00.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in the 420 with CNW by CannabisNewsWire. Cannabis has come a long way indeed. Despite suffering federal prohibition for decades, attitudes towards the plant are changing, and more people are looking at cannabis with an open mind. At the moment, numerous states have legalized either medical or recreational marijuana, or even both, and despite the current coronavirus crisis, there are several legalization initiatives currently in the works.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Thursday's trading session at $0.0154, even for the day, on 873,422 volume with 87 trades. The average volume for the last 3 months is 1,079,426 and the stock's 52-week low/high is $0.0092/$2.70000004.

Recent News

chart

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (OTCQB: NUGS).

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced new projections for calendar Q2 sales. According to the update and based on its performance in April and May, the Company is now on pace for over $2.7 million in quarterly sales and approximately $11 million in annualized sales. To view the full press release, visit http://cnw.fm/6uEFE

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), closed Thursday's trading session at $0.0759, up 3.9726%, on 2,541,031 volume with 248 trades. The average volume for the last 3 months is 1,289,334 and the stock's 52-week low/high is $0.025499999/$0.959999978.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Wednesday released its audited consolidated financial statements for the fiscal year ended March 31, 2020 ("FY 2020") and management's discussion and analysis ("MD&A") for the three and twelve months ended March 31, 2020. To view the full press release, visit http://cnw.fm/3CjLn

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Thursday's trading session at $0.9273, off by 8.1881%, on 87,364 volume with 168 trades. The average volume for the last 3 months is 98,148 and the stock's 52-week low/high is $0.371499985/$3.00.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.